or Try an Advanced Search...

    Treatment Of Cancer Stocks List

    Symbol Grade Name % Change
    ALLR F Allarity Therapeutics, Inc. -0.11
    BMRN F BioMarin Pharmaceutical Inc. 1.34
    GMAB F Genmab A/S 1.10
    IMTX F Immatics N.V. 0.26
    IOBT F IO Biotech, Inc. 3.37
    STTK F Shattuck Labs, Inc. -0.99
    NCNA F NuCana plc -2.36
    RAPT F RAPT Therapeutics, Inc. 1.43
    VINC F Vincera Pharma, Inc. 3.55
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Medical Instruments & Supplies Other Scientific & Technical Instruments
    Related Stock Lists: Cancer Biopharmaceutical Biotechnology Medicine Clinical Medicine Lymphoma Solid Tumors Autoimmune Disease Drug Discovery Drugs Health Sciences Immune System Immunology Immunotherapies Life Sciences Virotherapy Achondroplasia Acute Myeloid Leukemia Adoptive Cell Transfer Advanced Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Cancer stocks.

    Symbol Grade Name Weight
    IDNA D iShares Genomics Immunology and Healthcare ETF 8.13
    PBE D PowerShares Dynamic Biotech & Genome 7.64
    BBP C BioShares Biotechnology Products Fund 5.16
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 5.13
    FBT D First Trust Amex Biotech Index Fund 4.51
    View all Treatment Of Cancer ETFs...
    Compare ETFs
    Compare BBP to FBT Compare IDNA to PBE Compare PBE to BBP

        Treatment Of Cancer Stocks Recent News

        Date Stock Title
        Nov 21 BMRN Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?
        Nov 21 GMAB Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?
        Nov 21 BMRN BioMarin: Challenges Mount, But Sale Rumors Make For A Risky 'Buy' Call
        Nov 21 BMRN Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
        Nov 20 IMTX Immatics N.V. (NASDAQ:IMTX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
        Nov 19 BMRN BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 IMTX Immatics Sees Revenue Surge Despite R&D Expenses
        Nov 18 ALLR Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
        Nov 18 IMTX Immatics GAAP EPS of -€0.11, revenue of €50.56M
        Nov 18 IMTX Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME
        Nov 16 BMRN BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024
        Nov 16 STTK Shattuck Labs Third Quarter 2024 Earnings: Beats Expectations
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Medical Instruments & Supplies Other Scientific & Technical Instruments
        Related Stock Lists: Cancer Biopharmaceutical Biotechnology Lymphoma Solid Tumors Cell Therapy Disease Hematological Malignancies Life Sciences Pharmaceutical Products Protein Kinase Inhibitor Small Molecule Therapies Tyrosine Kinase Acute Leukemia Adoptive Cell Transfer Aging Associated Diseases Anaplastic Lymphoma Kinase Antibody Drug Conjugate Antiestrogens Biology
        Treatment Of Cancer

        Treatment of cancer depends on the type and stage of the cancer, as well as the patient's overall health and preferences. Treatment options may include surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and/or hormone therapy. In some cases, a combination of treatments may be used.

        Browse All Tags